Cargando…

A Novel Subset of Triple-Negative Breast Cancers with Unique Histology and Immunohistochemical Expression

BACKGROUND & OBJECTIVE: Triple-Negative Breast Carcinoma (TNBC) is characterized by an absence of estrogen receptor, progesterone receptor and HER2 neu expression, with distinct molecular, histological and clinical features, aggressive clinical course and a poor prognosis. The objective was to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalyanasundaram, Swaminathan, Kalyanaraman, Shantaraman, Kaleelullah Fathima, Hidhaya, Mohan, Vidhya, Selvaraj, Kavitha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Society of Pathology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013874/ https://www.ncbi.nlm.nih.gov/pubmed/35463732 http://dx.doi.org/10.30699/IJP.2022.139734.2526

Ejemplares similares

Glycans unique to the relapse-prone subset within triple-negative breast cancer as revealed by lectin array-based analysis of surgical specimens
por: Sakata-Matsuzawa, Madoka, et al.
Publicado: (2021)

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
por: Tischkowitz, Marc, et al.
Publicado: (2007)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2021)

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
por: da Silva, Jesse Lopes, et al.
Publicado: (2021)

Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer
por: Cubukcu, Erdem, et al.
Publicado: (2014)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer
por: Li, Meng, et al.
Publicado: (2022)

Clinicopathlogic and Immunohistochemical Characteristics of Triple Negative Invasive Lobular Carcinoma
por: Koo, Ja Seung, et al.
Publicado: (2011)

Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers
por: Liu, Yan-Xi, et al.
Publicado: (2016)

Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
por: Sun, Woo Young, et al.
Publicado: (2016)

Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas
por: Hidalgo, Jose Villacorta, et al.
Publicado: (2014)

Triple negative breast cancer: special histological types and emerging therapeutic methods
por: Cao, Lu, et al.
Publicado: (2020)

Phenylhydrazine hydrochloride induced dosedependent embryo cytotoxicity in zebrafish
por: Rajagopal, Raskin Erusan, et al.
Publicado: (2019)

Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2020)

The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
por: Liao, Hong-Ye, et al.
Publicado: (2018)

PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells
por: Byerly, Jessica, et al.
Publicado: (2016)

Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
por: Pareja, Fresia, et al.
Publicado: (2016)

γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers
por: Trošt, Nuša, et al.
Publicado: (2015)

Rare Breast Malignancy Subtypes: A Cytological, Histological, and Immunohistochemical Correlation
por: Kaur, Manmeet, et al.
Publicado: (2019)

Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
por: de la Cruz-Merino, Luis, et al.
Publicado: (2021)

Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2021)

Immunohistochemical Markers in Breast Cancer: A Cross-Sectional Study on Triple-Negative Breast Cancer in a Rural Tertiary Care Hospital
por: BA, Rakesh, et al.
Publicado: (2021)

Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas
por: Kostianets, Olga, et al.
Publicado: (2012)

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
por: Bottai, Giulia, et al.
Publicado: (2016)

Correction: γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers
por: Trošt, Nuša, et al.
Publicado: (2019)

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer
por: Chun, Brie, et al.
Publicado: (2022)

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020)

Correlation between PET/CT results and histological and immunohistochemical findings in breast carcinomas
por: Bitencourt, Almir Galvão Vieira, et al.
Publicado: (2014)

Immunohistochemical expression of basement membrane laminin in histological grades of oral squamous cell carcinoma: A semiquantitative analysis
por: Shruthy, R, et al.
Publicado: (2013)

Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
por: Abuderman, Abdulwahab A., et al.
Publicado: (2020)

Polo-Like Kinase 1(PLK1) Immunohistochemical Expression in Triple Negative Breast Carcinoma: A Probable Therapeutic Target
por: Salama, Maha E, et al.
Publicado: (2021)

Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients
por: Schmidt, Gilda, et al.
Publicado: (2022)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis
por: Sanges, Francesca, et al.
Publicado: (2020)

Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma
por: Jing, Na, et al.
Publicado: (2020)

Psychosocial Problems of Rural Indian Women Practising Breast Self-Examination – a Community-Based Study from Southern India
por: Balaiah Mehanathan, Pabithadevi, et al.
Publicado: (2023)

Histological and immunohistochemical studies on primary gastrointestinal lymphomas.
por: Lee, J. D., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_o8rt9thui5ul7uel8tqt8kd8bn